Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Role of the Tumor Microenvironment in Colorectal Cancer and the Potential Therapeutic Approaches Publisher Pubmed



Zafari N1 ; Khosravi F2 ; Rezaee Z3 ; Esfandyari S4 ; Bahiraei M5 ; Bahramy A3 ; Ferns GA6 ; Avan A7, 8, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  3. 3. Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  4. 4. Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Radiology, Besat Hospital, Hamedan University of Medical Sciences, Hamedan, Iran
  6. 6. Brighton & Sussex Medical School, Division of Medical Education, Sussex, United Kingdom
  7. 7. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  9. 9. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Journal of Clinical Laboratory Analysis Published:2022


Abstract

Background: Colorectal cancer (CRC) with a high prevalence is recognized as the fourth most common cause of cancer-related death globally. Over the past decade, there has been growing interest in the network of tumor cells, stromal cells, immune cells, blood vessel cells, and fibroblasts that comprise the tumor microenvironment (TME) to identify new therapeutic interventions. Methods: Databases, such as Google Scholar, PubMed, and Scopus, were searched to provide an overview of the recent research progress related to targeting the TME as a novel therapeutic approach. Results: Tumor microenvironment as a result of the cross talk between these cells may result in either advantages or disadvantages in tumor development and metastasis, affecting the signals and responses from the surrounding cells. Whilst chemotherapy has led to an improvement in CRC patients' survival, the metastatic aspect of the disease remains difficult to avoid. Conclusions: The present review emphasizes the structure and function of the TME, alterations in the TME, its role in the incidence and progression of CRC, the effects on tumor development and metastasis, and also the potential of its alterations as therapeutic targets. It should be noted that providing novel studies in this field of research might help us to achieve practical therapeutic strategies based on their interaction. © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Other Related Docs
14. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
22. Iran Diabetes Research Study; Knowledge Discovery in Diagnosis: A Scoping Review, Journal of Diabetes and Metabolic Disorders (2021)
29. Cancer-Associated Immune Cells and Their Modulation by Melatonin, Immunopharmacology and Immunotoxicology (2023)
37. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
38. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
42. Aging and Cancer Prognosis, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
44. Macrophage’S Role in Solid Tumors: Two Edges of a Sword, Cancer Cell International (2023)